Results for knoglemarvsceller translation from Danish to English

metafaseanalyse af knoglemarvsceller
metaphase analysis of bone marrow cells

der kunne ikke detekteres cytotoksiske virkninger af erytropoietin på knoglemarvsceller.
cytotoxic actions of erythropoietin on bone marrow cells could not be detected.

anakinra forøgede heller ikke antallet af kromosomabnormaliteter eller micronuclei i knoglemarvsceller hos mus.
neither did anakinra increase the incidence of chromosomal abnormalities or micronuclei in bone marrow cells in mice.

anakinra forøgede heller ikke antallet af kromosom abnormaliteter eller micronuclei i knoglemarvsceller hos mus.
neither did anakinra increase the incidence of chromosomal abnormalities or micronuclei in bone marrow cells in mice.

patienter med lav produktion af antistoffer som følge af transplantation af knoglemarvsceller fra en anden person.
patients with low antibody production following transplantation of bone marrow cells from another person.

i cellekulturer af humane knoglemarvsceller stimulerer epoetin alfa specifikt erytropoiese, og det påvirker ikke leukopoiese.
in cell cultures of human bone marrow cells, epoetin alfa stimulates erythropoiesis specifically and does not affect leucopoiesis.

i kulturer af humane knoglemarvsceller er det påvist, at epoetin alfa specifikt stimulerer erythropoiesen og ikke påvirker leukopoiesen.
it could be shown with the aid of cell cultures of human bone marrow cells that epoetin alfa stimulates erythropoiesis specifically and does not affect leucopoiesis.

det kan vises ved hjælp af cellekulturer fra humane knoglemarvsceller, at epoetin beta stimulerer specielt erythropoiese og ikke påvirker leukopoiese.
investigations in cell cultures of human bone marrow cells showed that epoetin beta stimulates erythropoiesis specifically and does not affect leucopoiesis.

studier med humane knoglemarvsceller viste også, at direkte eksponering for olaparib kan medføre toksicitet overfor knoglemarvsceller i ex vivo-analyser.
studies using human bone marrow cells also showed that direct exposure to olaparib can result in toxicity to bone marrow cells in ex vivo assays.

som "konditionerende behandling" (forberedelsesbehandling) inden transplantation af knoglemarvsceller (de celler, der producerer blodlegemer).
as a ‘conditioning’ (preparative) treatment before transplantation of haematopoietic progenitor cells (the cells that make blood cells).

derefter udvindes cd34+- cellerne (de celler, som kan lave lymfocytter) fra knoglemarvscellerne.
then, cd34+ cells (cells that can make lymphocytes) are extracted from the bone marrow cells.